Mach7 Completes On-Market Share Buy-Back
Key points
- Mach7's on-market share buy-back program ended on 3 March 2026
- 6,273,000 shares were purchased for $2,236,019.43 at an average price of $0.3501
- The buy-back program was announced on 30 January 2025
Full summary
Mach7 Technologies Limited (ASX:M7T) has announced the completion of its on-market share buy-back program. The buy-back program was originally announced on 30 January 2025, with the Company stating it would purchase up to $5M of fully paid ordinary shares. The buy-back program ended on 3 March 2026, with a total of 6,273,000 shares purchased for $2,236,019.43 at an average price of $0.3501 per share. Further details of the completed buy-back program have been lodged with the ASX. Mach7 Technologies is a leading provider of medical imaging software, delivering advanced data management and diagnostic viewing solutions to healthcare organizations worldwide. The Company's Mach7 Enterprise Imaging Solution (EIS) is a next-generation solution combining a powerful Vendor Neutral Archive (VNA), the eUnity Enterprise Diagnostic Viewer, and robust diagnostic workflow applications.
Summary generated by a large language model. Please interpret with care.